Key Record Dates
ClinicalTrials.gov Identifier: | NCT04606914 |
---|---|
Brief Title: | Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer |
First Submitted : | October 16, 2020 |
First Submitted that Met QC Criteria : | October 22, 2020 |
First Posted : | October 28, 2020 |
Last Update Submitted that Met QC Criteria : | November 27, 2023 |
Last Update Posted : | November 30, 2023 |